Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines.
about
In-vivo transfection of pcDNA3.1-IGFBP7 inhibits melanoma growth in mice through apoptosis induction and VEGF downexpressionBuilding a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance.Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.Proteasome inhibition blocks NF-κB and ERK1/2 pathways, restores antigen expression, and sensitizes resistant human melanoma to TCR-engineered CTLsTumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models.Celastrol potentiates radiotherapy by impairment of DNA damage processing in human prostate cancer.Proteasome inhibitor MG-132 induces C6 glioma cell apoptosis via oxidative stress.Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspects2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels.The proteasome inhibitor lactacystin exerts its therapeutic effects on glioma via apoptosis: an in vitro and in vivo study.Functional expression of voltage-gated calcium channels in human melanoma.Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway.Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction.Expression of somatostatin receptors in human melanoma cell lines: effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation.Celastrol causes apoptosis and cell cycle arrest in rat glioma cells.Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.Proteasome inhibitors against amelanotic melanoma.
P2860
Q33748866-7A196E54-DC77-4B4F-8741-E4D0AA40E7A9Q34015408-F5C89481-1024-4D35-B52C-3EC349A78B20Q35419895-D62380B9-D448-4598-80C9-1EAF956F9FE0Q36028423-4FA17D3E-ABE4-4E6C-AB04-2B6AE2944BBDQ37269038-C0113EC1-37C2-4EE0-8A5C-AEC7B6D01859Q37349650-60A88463-4816-4563-A4ED-4343E73CE8A1Q37728340-ECDF6AE2-E60D-42D4-89DC-E79EFE717A47Q37948056-2D5F75EA-CEB7-4E20-A467-901B4119ADB1Q38785352-C14D6205-5BF7-42C8-BF5B-8F18BDD1F123Q39169079-F43808C1-BDBE-44C2-BAB4-406EC178288CQ39409759-69A35D0D-8502-44AB-9ECA-9FD304016281Q39568919-31BB6DD6-3E76-462E-8342-68DF29D36299Q39619870-F016A044-D897-4124-97B6-7710437A9AEFQ39741277-E6A38B88-998B-4B6A-BC52-01ACCFC600BEQ39775649-A57C3C9C-B696-4E9E-8F0D-0E5181279EFEQ42632400-336E6934-BA9C-410A-91CF-63BA8EAF778EQ47141204-4BC64B40-F109-40B3-95D9-E24C117C3021
P2860
Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Effect of proteasome inhibitor ...... s melanoma-derived cell lines.
@en
type
label
Effect of proteasome inhibitor ...... s melanoma-derived cell lines.
@en
prefLabel
Effect of proteasome inhibitor ...... s melanoma-derived cell lines.
@en
P2093
P50
P1476
Effect of proteasome inhibitor ...... us melanoma-derived cell lines
@en
P2093
A Llombart
A M Pérez de Santos
A Yeramian
J M Casanova
X Matias-Guiu
P304
P356
10.1111/J.1365-2133.2007.08390.X
P407
P577
2008-01-17T00:00:00Z